Press "Enter" to skip to content

Pfizer Japan recalls high blood pressure drug over cancer-causing impurity

The Japanese subsidiary of Pfizer Inc is recalling a drug for high blood pressure which was found to contain a carcinogenic substance in its active ingredient valsartan, the drugmaker said on Friday.

Also Read:   Alembic gets USFDA nod for Tizanidine hydrochloride capsules used to treat spasticity